Novo Nordisk Singled Out by Sanders, Biden

On Tuesday, September 24th, 2024, Lars Fruergaard Jørgensen, CEO of the Danish pharmaceutical company, Novo Nordisk A/S, was grilled in the United States Senate over the pricing of the type II diabetes and weight loss drugs, Ozempic and Wegovy.